Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fruman

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
The Journal of Biological Chemistry|January 1, 2013
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte functionLomon So, Sung Su Yea, Jean S Oak, et al.
Science Advances|December 5, 2020
YAP-mediated mechanotransduction tunes the macrophage inflammatory responseVijaykumar S Meli, Hamza Atcha, Praveen Krishna Veerasubramanian, et al.
Blood|October 28, 2016
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignanciesChangchun Deng, Mark R Lipstein, Luigi Scotto, et al.
Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Cancer Research Communications|November 13, 2023
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 InhibitorsDennis Juarez, Roberta Buono, Shannon M Matulis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligandsXiaocui Zhu, Rebecca Hart, Mi Sook Chang, et al.
Oncotarget|March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemiaQi Zhang, Ce Shi, Lina Han, et al.
Science Translational Medicine|June 15, 2018
Statins enhance efficacy of venetoclax in blood cancersJ Scott Lee, Andrew Roberts, Dennis Juarez, et al.
The EMBO Journal|June 30, 2025
Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1AVaishali Jayashankar, Peter Kubiniok, Alison N McCracken, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
The Journal of Biological Chemistry|January 1, 2013
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte functionLomon So, Sung Su Yea, Jean S Oak, et al.
Science Advances|December 5, 2020
YAP-mediated mechanotransduction tunes the macrophage inflammatory responseVijaykumar S Meli, Hamza Atcha, Praveen Krishna Veerasubramanian, et al.
Blood|October 28, 2016
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignanciesChangchun Deng, Mark R Lipstein, Luigi Scotto, et al.
Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Cancer Research Communications|November 13, 2023
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 InhibitorsDennis Juarez, Roberta Buono, Shannon M Matulis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligandsXiaocui Zhu, Rebecca Hart, Mi Sook Chang, et al.
Oncotarget|March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemiaQi Zhang, Ce Shi, Lina Han, et al.
Science Translational Medicine|June 15, 2018
Statins enhance efficacy of venetoclax in blood cancersJ Scott Lee, Andrew Roberts, Dennis Juarez, et al.
The EMBO Journal|June 30, 2025
Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1AVaishali Jayashankar, Peter Kubiniok, Alison N McCracken, et al.
Pageof 11